L251-1223 Screening compound: 2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[(3-fluorophenyl)methyl]propanamide

L251-1223 Screening compound: 2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[(3-fluorophenyl)methyl]propanamide
L251-1223 Screening compound: 2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[(3-fluorophenyl)methyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L251-1223
2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[(3-fluorophenyl)methyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L251-1223

Molecular Formula

C26H27F2N3O2S (C26 H27 F2 N3 O2 S)

Compound Name

2-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]piperidin-4-yl}-N-[(3-fluorophenyl)methyl]propanamide

IUPAC name

2-{1-[2-(4-fluorophenyl)-4-methyl-13-thiazole-5-carbonyl]piperidin-4-yl}-N-[(3-fluorophenyl)methyl]propanamide

SMILES

CC(C(CC1)CCN1C(c1c(C)nc(-c(cc2)ccc2F)s1)=O)C(NCc1cc(F)ccc1)=O

InChI

InChI=1S/C26H27F2N3O2S/c1-16(24(32)29-15-18-4-3-5-22(28)14-18)19-10-12-31(13-11-19)26(33)23-17(2)30-25(34-23)20-6-8-21(27)9-7-20/h3-9,14,16,19H,10-13,15H2,1-2H3,(H,29,32)/t16-/m0/s1

InChI Key

XDBWTJYYLHVXER-INIZCTEOSA-N

MDL Number (MFCD)

MFCD27238226

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.580

Distribution Coefficient, logD

4.580

Water Solubility, LogSw

-4.38

Polar Surface Area

51.611

Acid Dissociation Constant (pKa)

12.56

Base Dissociation Constant (pKb)

0.82

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

34.60

L251-1223 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with L251-1223 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L251-1223?
Check Price and Availability of L251-1223, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L251-1223 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L251-1223
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L251-1223
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L251-1223 available by request